跨境通(002640.SZ):股東徐佳東已被動減持1.02%股份
格隆匯2月19日丨跨境通(002640.SZ)公佈,公司於2020年12月12日發佈《關於持股5%以上股東存在被動減持公司股份風險的提示性公吿》,公司持股5%以上股東徐佳東因涉及債務糾紛,其個人名下股份存在被司法強制執行、執行股權質押協議等被動減持的風險。
近日,公司收到徐佳東提交的《關於股份被動減持計劃實施數量過半的吿知函》,截至該公吿披露日,此次被動減持計劃已合計減持1593.2759萬股,佔公司總股本的1.02%,實施數量已過半。徐佳東仍持有公司股份約1.6416億股,佔公司總股本的10.54%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.